Protective effect and molecular mechanisms of magnesium acetyltaurate against endothelin-1- induced retinal and optic nerve damage in rats: focus on neuroinflammation / Natasha Najwa Nor Arfuzir by Nor Arfuzir, Natasha Najwa
UNIVERSITI TEKNOLOGI MARA 
PROTECTIVE EFFECT AND 
MOLECULAR MECHANISMS OF 
MAGNESIUM ACETYLTAURATE 
AGAINST ENDOTHELIN-1-
INDUCED RETINAL AND OPTIC 
NERVE DAMAGE IN RATS: FOCUS 
ON NEUROINFLAMMATION 
NATASHA NAJWA BINTI NOR ARFUZIR 
Thesis submitted in fulfillment 
of the requirements for the degree of 
Doctor of Philosophy in Medical Science 
(Pharmacology) 
Faculty of Medicine 
February 2020 
AUTHOR'S DECLARATION 
I declare that the work in this thesis was carried out in accordance with the regulations 
of Universiti Teknologi MARA. It is original and is the results of my own work, unless 
otherwise indicated or acknowledged as referenced work. This thesis has not been 
submitted to any other academic institution or non-academic institution for any degree 
or qualification. 
I, hereby, acknowledge that I have been supplied with the Academic Rules and 
Regulations for Post Graduate, Universiti Teknologi MARA, regulating the conduct of 
my study and research. 
Name of Student 
Student ID. No. 
Programme 
Faculty 
Thesis Title 
Natasha Naj wa binti Nor Arfuzir 
2014991763 
Doctor of Philosophy in Medical Science 
(Pharmacology) - MD958 
Medicine 
Protective Effect and Molecular Mechanisms of 
Magnesium Acetyltaurate Against Endothelin-1-
Induced Retinal and Optic Nerve Damage in Rats: 
Focus on Neuroinflammation 
Signature of Student 
Date February 2020 
in 
ABSTRACT 
Ischaemic retinal and optic nerve injury causes several ocular conditions including 
glaucoma, the leading cause of irreversible blindness. Glaucoma is characterized by loss 
of retinal ganglion cells (RGCs). All current antiglaucoma medications primarily act by 
lowering elevated intraocular pressure, the major risk factor for glaucoma, without 
providing direct neuroprotection to RGCs. The ischaemia in glaucomatous retina causes 
excessive glutamate accumulation and excitotoxicity. As a result, Ca2+ overload in glial 
cells causes release of reactive oxygen and nitrogen species (RONS) and inflammatory 
cytokines including interleukin (TL)-ip, IL-6 and tumour necrosis factor (TNF)-a via 
activation of c-Jun and NFKp. In addition to glial derived RONS and inflammatory 
cytokines, Ca2+ overload causes c-Jun and NFKp activation in RGCs as well. This 
further escalates RONS generation and activates caspases and pro-apoptotic factors. 
Since both the Mg2+ and taurine are known to inhibit ischaemia, Ca2+ overload and 
apoptotic pathways, magnesium acetyltaurate (MgAT) was synthesised and its 
neuroprotective effects and mechanisms of action against endothelin (ET1) induced 
retinal and optic nerve injury were investigated in Sprague dawley rats. MgAT was 
administered intravitreally as pre-, co- and post-treatment with ET1. Seven days later 
rats were euthanised and eyes were enucleated. Eyeballs were processed for 
examination of retinal morphology using hematoxylin and eosin staining, optic nerve 
morphology using toluidine blue staining, retinal expression of 3 nitric oxide synthase 
(NOS) isoforms using immunohistochemistry, retinal nitrosative and oxidative stress 
markers using ELISA, extent of retinal cell apoptosis using caspase-3 and TUNEL 
immunostaining. Among the 3 MgAT treatment groups, pre-treatment was found to 
most effectively preserve retinal and optic nerve morphology by restoring the 
expression of NOS isoforms and reducing nitrosative and oxidative stress. In this group 
there were significantly lower number of caspase-3 and TUNEL positive cells compared 
to vehicle treated rats indicating lower number of retinal cells undergoing apoptosis. In 
the next part of study, the neuroprotective effects of MgAT were compared with that of 
taurine alone using the same parameters. It was observed that MgAT provides greater 
neuroprotection compared to taurine alone against ET1 induced ischaemic retinal 
injury. Since the pre-treatment with MgAT was found to be most effective, in 
subsequent studies, the mechanisms of neuroprotective effect of MgAT were 
investigated by administering it as pre-treatment with ET1. MgAT pre-treatment 
prevents ET1 induced increase in retinal expression of cytokines, c-Jun, phospho c-Jun, 
NFKP and phospho NFKp. Further, it was investigated if MgAT pre-treatment could 
prolong the RGC survival and retrograde labelling of RGC was done using fluorogold 
as a neuronal tracer. It was observed that there was significantly greater number of 
fluorogold positive cells in MgAT pre-treated group, indicating greater RGC survival. 
Additionally, Brn3a immunostaining was also done on retinal sections to assess RGC 
survival. It was observed that treatment with ET1 results in significantly lower number 
of Brn3a+ RGCs, however, pre-treatment with MgAT caused appearance of several 
Brn3a+ RGCs indicating greater RGC survival. At last, visual function test was 
performed to determine the functional outcome of the neuroprotective effect of MgAT. 
Object recognition test using Morris water maze showed that MgAT pre-treatment 
abolishes the ET1 induced impairment of visual functions. In conclusion, MgAT 
protects RGCs by inhibiting expression of inflammatory cytokines, restoring the 
expression of NOS isoforms and preventing retinal oxidative and nitrosative stress. 
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